Резултати

eNauka >  Results >  Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial
Title: Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial
Authors: Atreya, Raja; Peyrin-Biroulet, Laurent; Klymenko, Andrii; Augustyn, Monica; Bakulin, Igor; Slankamenac, Dusan S; Miheller, Pal; Gasbarrini, Antonio; Hebuterne, Xavier; Arnesson, Karin;
Knittel, Thomas; Kowalski, Jan; Neurath, Markus F; Sandborn, William J; Reinisch, Walter;
Issue Date: 2020
Publication: LANCET GASTROENTEROLOGY & HEPATOLOGY
ISSN: 2468-1253 Lancet Gastroenterology & Hepatology Search Idenfier
Type: Article
Collation: vol. 5 br. 12 str. 1063-1075
DOI: 10.1016/S2468-1253(20)30301-0
WoS-ID: 000590851100016
Scopus-ID: 2-s2.0-85095423249
URI: https://enauka.gov.rs/handle/123456789/832151
Project: InDex Pharmaceuticals
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

44
SCOPUSTM
16
OpenCitations
42
WEB OF SCIENCETM
Алт метрика
Dimensions
Unpaywall

Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.